Lexicon Pharmaceuticals
LXRX
LXRX
103 hedge funds and large institutions have $1.02B invested in Lexicon Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 103 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
103
Holders Change
+103
Holders Change %
–
% of All Funds
3.36%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.07%
New
103
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AG
1
Artal Group
Luxembourg
|
$550M |
2 |
![]()
2
Fidelity Investments
Boston,
Massachusetts
|
$167M |
3 |
UL
3
Ulys LLC
New York
|
$64.6M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$31.9M |
5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$31.3M |
Top Sellers
No sellers this quarter